Open AccessRare complication of a commonly used antihypertensive agent: A case of hydralazine‐induced ANCA‐associated vasculitis presenting as rapidly progressive glomerulonephritis
Author(s) -
Warren Kayle,
Vu Khiem,
Shergill Karandeep,
Watson Brian,
Faris Mohamed
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5411
Subject(s) - medicine , hydralazine , rapidly progressive glomerulonephritis , pulmonary hemorrhage , vasculitis , glomerulonephritis , complication , anca associated vasculitis , intensive care medicine , lung , kidney , disease , blood pressure
Hydralazine‐induced ANCA‐associated vasculitis is a rare clinical entity, with complications including rapidly progressive glomerulonephritis, pulmonary hemorrhage, and pulmonary‐renal syndrome. We present this case to highlight the clinical features that support this challenging diagnosis and to emphasize the importance of prompt recognition and aggressive intervention given its significant morbidity and mortality.